K110909 is an FDA 510(k) clearance for the EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM, BAREWIRE FILTER DELIVERY WIRE-WORK.... Classified as Temporary Carotid Catheter For Embolic Capture (product code NTE), Class II - Special Controls.
Submitted by Abbott Laboratories (Santa Clara, US). The FDA issued a Cleared decision on April 29, 2011 after a review of 29 days - a notably fast clearance cycle.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.
View all Abbott Laboratories devices
NCT00402740
Completed
Interventional
Industry-sponsored
Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)
Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)
| Condition studied |
Carotid Artery Disease |
| Study design |
Single group |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Seemant Chaturvedi, MD |
| Sponsor |
Abbott Medical Devices
(industry)
|
Started 2006-11-01
→
Primary completion 2011-06-01
→
Completed 2011-10-01
Primary outcome
Kaplan-Meier Estimate of Freedom From the Composite of Any Death, Stroke and MI During the 30 Day Post Procedural Period (DSMI), Plus Fatal and Non-fatal Ipsilateral Stroke From 31-365 Days and Annually Thereafter for a Total of 3 Years.
Secondary outcome
Acute Device Success
View full study on ClinicalTrials.gov